276 related articles for article (PubMed ID: 36338055)
41. Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome.
Xi J; Ding D; Zhu H; Wang R; Su F; Wu W; Xiao Z; Liang X; Zhao Q; Hong Z; Fu H; Xiao Q
BMC Microbiol; 2021 Aug; 21(1):226. PubMed ID: 34384375
[TBL] [Abstract][Full Text] [Related]
42. Improved Metabolite Prediction Using Microbiome Data-Based Elastic Net Models.
Xie J; Cho H; Lin BM; Pillai M; Heimisdottir LH; Bandyopadhyay D; Zou F; Roach J; Divaris K; Wu D
Front Cell Infect Microbiol; 2021; 11():734416. PubMed ID: 34760716
[TBL] [Abstract][Full Text] [Related]
43. Comparison of Fecal Collection Methods on Variation in Gut Metagenomics and Untargeted Metabolomics.
Guan H; Pu Y; Liu C; Lou T; Tan S; Kong M; Sun Z; Mei Z; Qi Q; Quan Z; Zhao G; Zheng Y
mSphere; 2021 Oct; 6(5):e0063621. PubMed ID: 34523982
[TBL] [Abstract][Full Text] [Related]
44. Faecal Microbiota Transplantation Reduces Susceptibility to Epithelial Injury and Modulates Tryptophan Metabolism of the Microbial Community in a Piglet Model.
Geng S; Cheng S; Li Y; Wen Z; Ma X; Jiang X; Wang Y; Han X
J Crohns Colitis; 2018 Nov; 12(11):1359-1374. PubMed ID: 30010734
[TBL] [Abstract][Full Text] [Related]
45. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome.
Qi X; Yun C; Sun L; Xia J; Wu Q; Wang Y; Wang L; Zhang Y; Liang X; Wang L; Gonzalez FJ; Patterson AD; Liu H; Mu L; Zhou Z; Zhao Y; Li R; Liu P; Zhong C; Pang Y; Jiang C; Qiao J
Nat Med; 2019 Aug; 25(8):1225-1233. PubMed ID: 31332392
[TBL] [Abstract][Full Text] [Related]
46. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study.
Zeng B; Lai Z; Sun L; Zhang Z; Yang J; Li Z; Lin J; Zhang Z
Res Microbiol; 2019; 170(1):43-52. PubMed ID: 30292647
[TBL] [Abstract][Full Text] [Related]
47. Metagenomic-based characterization of the gut virome in patients with polycystic ovary syndrome.
Huang L; Wu X; Guo S; Lv Y; Zhou P; Huang G; Duan Z; Sun W
Front Microbiol; 2022; 13():951782. PubMed ID: 36051758
[TBL] [Abstract][Full Text] [Related]
48. High-Fiber Diet or Combined With Acarbose Alleviates Heterogeneous Phenotypes of Polycystic Ovary Syndrome by Regulating Gut Microbiota.
Wang X; Xu T; Liu R; Wu G; Gu L; Zhang Y; Zhang F; Fu H; Ling Y; Wei X; Luo Y; Shen J; Zhao L; Peng Y; Zhang C; Ding X
Front Endocrinol (Lausanne); 2021; 12():806331. PubMed ID: 35185786
[TBL] [Abstract][Full Text] [Related]
49. Reduced stress-associated FKBP5 DNA methylation together with gut microbiota dysbiosis is linked with the progression of obese PCOS patients.
Chen F; Chen Z; Chen M; Chen G; Huang Q; Yang X; Yin H; Chen L; Zhang W; Lin H; Ou M; Wang L; Chen Y; Lin C; Xu W; Yin G
NPJ Biofilms Microbiomes; 2021 Jul; 7(1):60. PubMed ID: 34267209
[TBL] [Abstract][Full Text] [Related]
50. Association between Polycystic Ovary Syndrome and Gut Microbiota.
Guo Y; Qi Y; Yang X; Zhao L; Wen S; Liu Y; Tang L
PLoS One; 2016; 11(4):e0153196. PubMed ID: 27093642
[TBL] [Abstract][Full Text] [Related]
51. Alteration in gut mycobiota of patients with polycystic ovary syndrome.
Chen K; Geng H; Liu J; Ye C
Microbiol Spectr; 2023 Sep; 11(5):e0236023. PubMed ID: 37702484
[TBL] [Abstract][Full Text] [Related]
52. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
Yurtdaş G; Akdevelioğlu Y
J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
[TBL] [Abstract][Full Text] [Related]
53. A Multi-omics Approach to Unraveling the Microbiome-Mediated Effects of Arabinoxylan Oligosaccharides in Overweight Humans.
Benítez-Páez A; Kjølbæk L; Gómez Del Pulgar EM; Brahe LK; Astrup A; Matysik S; Schött HF; Krautbauer S; Liebisch G; Boberska J; Claus S; Rampelli S; Brigidi P; Larsen LH; Sanz Y
mSystems; 2019 May; 4(4):. PubMed ID: 31138673
[TBL] [Abstract][Full Text] [Related]
54. 16S rDNA Full-Length Assembly Sequencing Technology Analysis of Intestinal Microbiome in Polycystic Ovary Syndrome.
Dong S; Jiao J; Jia S; Li G; Zhang W; Yang K; Wang Z; Liu C; Li D; Wang X
Front Cell Infect Microbiol; 2021; 11():634981. PubMed ID: 34041041
[TBL] [Abstract][Full Text] [Related]
55. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.
Chang AY; Lalia AZ; Jenkins GD; Dutta T; Carter RE; Singh RJ; Nair KS
Metabolism; 2017 Jun; 71():52-63. PubMed ID: 28521878
[TBL] [Abstract][Full Text] [Related]
56. Fecal Microbiota Transplantation Beneficially Regulates Intestinal Mucosal Autophagy and Alleviates Gut Barrier Injury.
Cheng S; Ma X; Geng S; Jiang X; Li Y; Hu L; Li J; Wang Y; Han X
mSystems; 2018; 3(5):. PubMed ID: 30320222
[TBL] [Abstract][Full Text] [Related]
57. An Integrated Outlook on the Metagenome and Metabolome of Intestinal Diseases.
Aw W; Fukuda S
Diseases; 2015 Nov; 3(4):341-359. PubMed ID: 28943629
[TBL] [Abstract][Full Text] [Related]
58. Comprehensive Analysis of the Relationships Between the Gut Microbiota and Fecal Metabolome in Individuals With Primary Sjogren's Syndrome by 16S rRNA Sequencing and LC-MS-Based Metabolomics.
Yang L; Xiang Z; Zou J; Zhang Y; Ni Y; Yang J
Front Immunol; 2022; 13():874021. PubMed ID: 35634334
[TBL] [Abstract][Full Text] [Related]
59. Multi-omics reveals specific host metabolism-microbiome associations in intracerebral hemorrhage.
Chen L; Wang S; Zhang Y; Li Y; Zhang X; Ma J; Zou X; Yao T; Li S; Chen J; Zhou H; Wu L; Zhou Y; Zhang L
Front Cell Infect Microbiol; 2022; 12():999627. PubMed ID: 36619742
[TBL] [Abstract][Full Text] [Related]
60. Non-invasive urinary metabolomics reveals metabolic profiling of polycystic ovary syndrome and its subtypes.
Zhou W; Hong Y; Yin A; Liu S; Chen M; Lv X; Nie X; Tan N; Zhang Z
J Pharm Biomed Anal; 2020 Jun; 185():113262. PubMed ID: 32222648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
